Biotech News
-
Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London
September 23, 2021 (Source) — This Was the World’s First Published Study Assessing MDMA-Assisted Psychotherapy as a Treatment for…
-
Valeo Pharma Announces Record Revenues and Gross Margins for its Third Quarter 2021
September 22, 2021 (Source) — Record revenues of $5.7 million for Q3 2021, up 280% over Q3 2020 and…
-
ZEN Graphene Solutions and Trebor Rx Announce Health Canada Approval for ZENGuard Mask
September 22, 2021 (Source) — ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused…
-
Sixth Wave and York University Successfully Pass Mitacs Accelerate Research Review
September 22, 2021 (Source) — Point-of-need Microfluidic Biosensor for Detecting Airborne Viruses using Molecularly Imprinted Polymers: Towards COVID-19 Virus…
-
Element Nutritional Sciences to Launch Innovative Sports Nutrition Product under JAKTRX™ Brand
September 22, 2021 (Source) — Plant-based amino acid formulation proven to increase muscle protein synthesis by 76% Sports…
-
Hemostemix Announces Closing of First Tranche of Unit Private Placement
September 21, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) announces it has…
-
Awakn Life Sciences to Present at the Oppenheimer and Maxim Group September Investor Conferences
September 20, 2021 (Source) — Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (‘Awakn’), a biotechnology company with clinical…
-
DIAGNOS Announces a Multi-Year Contract with Juarez Health & Medical Tourism Cluster
September 16, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a…
-
Awakn Life Sciences to Acquire Leading Ketamine-Assisted Psychotherapy Clinic in Norway
September 16, 2021 (Source) — Launches Nordics Regional Expansion Dr. Lowan Stewart, One of Europe’s Preeminent Ketamine Physicians, Appointed…
-
Valeo Pharma To Report Third Quarter 2021 Results and Hold Investors Conference Call / Webcast
September 16, 2021 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
